Literature DB >> 24833645

Impact of metabolic syndrome on left atrial electroanatomical remodeling and outcomes after radiofrequency ablation of nonvalvular atrial fibrillation.

Borislav Dinov1, Jedrzej Kosiuk2, Simon Kircher2, Andreas Bollmann2, Willem-Jan Acou2, Arash Arya2, Gerhard Hindricks2, Sascha Rolf2.   

Abstract

BACKGROUND: Recent studies reported worse outcomes after atrial fibrillation (AF) ablation in patients with metabolic syndrome (MetS). However, mechanisms of AF recurrence in MetS remain unclear. METHOD AND
RESULTS: We performed pulmonary vein isolation and voltage mapping in 236 patients with AF (age 61±9.6 years; persistent AF 64%; MetS 54%). Left atrial (LA) low voltage areas were semiquantitatively estimated and presented as low voltage index. MetS was defined according to National Cholesterol Education Program Adult Treatment Panel III. Follow-up for AF recurrence ≤12 months was performed. LA low voltage areas were observed in 46% of patients with MetS versus 8.2% patients without MetS ; P<0.0001. MetS was an independent predictor of LA low voltage areas: odds ratio, 11.64; 95% confidence interval, 4.381-30.903; P<0.0001. Observed AF recurrence at 12 months was 42.7% in MetS versus 36.1% in the non-MetS group (P=0.303). The presence of LA low voltage areas was a predictor of 12-month AF recurrence: odds ratio, 2.99; 95% confidence interval, 1.36-6.56; P=0.006. Probability of 12-month AF recurrence increased with 84.5% for every unit of low voltage Index.
CONCLUSIONS: MetS was not associated with worse outcomes after radiofrequency catheter ablation of AF, but LA low voltage areas were more frequently observed in patients with MetS. The presence and extent of LA low voltage areas may influence the long-term outcomes after catheter ablation.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  atrial fibrillation

Mesh:

Year:  2014        PMID: 24833645     DOI: 10.1161/CIRCEP.113.001185

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  21 in total

Review 1.  Atrial Fibrillation and Hypertension: Mechanistic, Epidemiologic, and Treatment Parallels.

Authors:  Adedotun A Ogunsua; Amir Y Shaikh; Mohamed Ahmed; David D McManus
Journal:  Methodist Debakey Cardiovasc J       Date:  2015 Oct-Dec

Review 2.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

3.  Association of Body Mass Index With Intracardiac Left Atrial Voltage in Patients With Atrial Fibrillation.

Authors:  M Benjamin Shoemaker; Jonathan Chrispin; Maureen Farrell; Shi Huang; Jay Montgomery; David Spragg; Joseph E Marine; Christopher R Ellis; Hugh Calkins; Saman Nazarian
Journal:  JACC Clin Electrophysiol       Date:  2018-06-06

Review 4.  Characteristics of PR interval as predictor for atrial fibrillation: association with biomarkers and outcomes.

Authors:  Katja Schumacher; Nikolaos Dagres; Gerhard Hindricks; Daniela Husser; Andreas Bollmann; Jelena Kornej
Journal:  Clin Res Cardiol       Date:  2017-04-05       Impact factor: 5.460

5.  Association between functional mitral regurgitation and recurrence of paroxysmal atrial fibrillation following catheter ablation: a prospective cohort study.

Authors:  Fusheng Ke; Yinhui Huang; Zhexiu Jin; Lei Huang; Qiang Xiong; Fang Jia; Yu Chen; Gang Chen
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

6.  EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  J Arrhythm       Date:  2016-07-11

7.  Genomic contributors to atrial electroanatomical remodeling and atrial fibrillation progression: Pathway enrichment analysis of GWAS data.

Authors:  Daniela Husser; Laura Ueberham; Borislav Dinov; Jedrzej Kosiuk; Jelena Kornej; Gerhard Hindricks; M Benjamin Shoemaker; Dan M Roden; Andreas Bollmann; Petra Büttner
Journal:  Sci Rep       Date:  2016-11-18       Impact factor: 4.379

8.  Functional mitral regurgitation: predictor for atrial substrate remodeling and poor ablation outcome in paroxysmal atrial fibrillation.

Authors:  Yu Qiao; Lingmin Wu; Bingbo Hou; Wei Sun; Lihui Zheng; Ligang Ding; Gang Chen; Shu Zhang; Yan Yao
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

9.  NT-proANP levels in peripheral and cardiac circulation.

Authors:  Petra Büttner; Timm Seewöster; Danilo Obradovic; Gerhard Hindricks; Holger Thiele; Jelena Kornej
Journal:  J Interv Card Electrophysiol       Date:  2021-06-25       Impact factor: 1.900

10.  Impact of Alcohol Consumption on Substrate Remodeling and Ablation Outcome of Paroxysmal Atrial Fibrillation.

Authors:  Yu Qiao; Rui Shi; Bingbo Hou; Lingmin Wu; Lihui Zheng; Ligang Ding; Gang Chen; Shu Zhang; Yan Yao
Journal:  J Am Heart Assoc       Date:  2015-11-09       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.